MedPath

Effect of Ayarij-e-Faiqra on functional constipatio

Phase 3
Conditions
functional constipation.
Constipation
K59.0
Registration Number
IRCT20200303046677N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

The ability to participate in the whole study
Absence of significant behavioral disorders
Speech in understandable language
Completion of the consent form and having at least six months of history of constipation according to Rome III criteria.

Exclusion Criteria

Sensitivity to herbal medicines
Diagnosis of obstructive constipation by a gastroenterologist based on history or colon transit
Consumption drugs that cause constipation in the recent month (anticholinergic drugs, tricyclic antidepressants, calcium channel blockers, anti-Parkinson's drugs, sympathomimetics, antipsychotics, diuretics, iron supplements, anti-inflammatory drugs, hormonal drugs)
Abuse narcotics, stimulants, cannabis, alcohol and pseudo pirates
Illnesses affecting constipation
Warning signs (rectal bleeding, weight loss or anemia)
Unpredictable complications were leading to intolerance to the drug or placebo such as idiosyncratic disease
Secondary constipation to diseases, and medications
Gastrointestinal complications that impede the continuation of the study
Unwilling to continue the study and lack of cooperation.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath